About Careers MedBlog Contact us

Hepatitis B Vaccinations Manage To Lower Infection Rates In Catalonia, Spain

by Rishika Gupta on March 14, 2019 at 7:28 PM
Font : A-A+

Hepatitis B Vaccinations Manage To Lower Infection Rates In Catalonia, Spain

Catalonia, Spain sees a huge decline of 52 percentage in hepatitis B infections. This decline has been found to be a result of hepatitis B vaccination programmes conducted among preteens twenty-one years ago.

The results of this study are published in the journal of Vaccine.


Introducing the Hepatitis B vaccine in preadolescents meant a decline in the disease incidence rate by 52 % according to a study in which the University of Barcelona (UB) took part. The study analyzed the efficiency and impact of the vaccination program set in Catalonia (Spain) twenty-one years ago. The results show that after introducing the program, the incidence rate in general population went from 2.5 per 100,000 people in 1991 to 1.2 per 100,000 people in 2014.

The study, published in the scientific journal Vaccine, counts on the participation of experts from the Research Group on Epidemiology, Prevention and Control of Communicable Diseases of the UB, the Public Health Agency of Catalonia and the Barcelona Public Health Agency, led by Professor Àngela Domínguez, from the Department of Medicine of the UB and the Epidemiology and Public Health Networking Biomedical Research Centre (CIBERESP, Institute of Health Carlos III).

Hepatitis B is a globally important viral disease due its morbidity, mortality and high chronicity in children. Chronicity increases the risk of cirrhosis and hepatocellular carcinoma, and patients with a chronic disease are permanent transmitters of the virus. In 1991, systematic vaccination for Hepatitis B was introduced in Catalonia in preadolescents. "So far, only risk groups were vaccinated, such as those working in the health sector or haemophiliac and haemodialytic patients. However, this type of vaccination was not enough to reduce the incidence", note the researchers.

An efficient program

Researchers studied retrospectively vaccinated and non-vaccinated cohorts, chosen according to their year of birth, as well as cases of Hepatitis B between 2000 and 2014 that were registered by the Sub-Directorate General for Epidemiological Surveillance and Public Health Emergency Response of the Public Health Agency of Catalonia. During that period, they notified about 388 cases of Hepatitis B infection, 232 in the non-vaccinated cohort and 156 in the vaccinated cohort.

The incidence rate was 4.1 per 100,000 people per year in the non-vaccinated group and 0.03 per 100,000 people per year in the vaccinated group. Therefore, the efficiency of the program was 99.30 % and the associated benefit to estimate the prevented fraction was of 64.56 %.

According to the researchers, these results show that "efficiency and impact of the vaccination program for Hepatitis B in preadolescents are high, benefiting the community."

Vaccination in preadolescents was suspended in July 2014, when the first kids who had been vaccinated as children (vaccinated in 2002, aged one) reached preadolescence, so they did not need the vaccine again.

Source: Eurekalert


Recommended Reading

Latest General Health News

 People Living Close to the Seaside Enjoy Better Health
Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.
 Over Four Million Gardeners Place Their Hearing in Danger
New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.
Breaking the Barrier: Unraveling Mucus Plugs to Save Lives in COPD
Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.
 Disease Modifying Therapies for Multiple Sclerosis Continue to Drive Up Healthcare Cost
The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.
 New Genetic Variant Provides Protection Against Alzheimer's Disease
A genetic variant in a patient protected from autosomal dominant Alzheimer's disease (ADAD) suggests a role for RELN signaling in resilience to dementia.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Hepatitis B Vaccinations Manage To Lower Infection Rates In Catalonia, Spain Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests